Observational study on evaluation of glycaemic control in patients using a modern insulin - NovoRapid (insulin aspart), NovoMix 30 (biphasic insulin aspart) or Levemir (insulin detemir) - for treatment of diabetes mellitus.

Trial Profile

Observational study on evaluation of glycaemic control in patients using a modern insulin - NovoRapid (insulin aspart), NovoMix 30 (biphasic insulin aspart) or Levemir (insulin detemir) - for treatment of diabetes mellitus.

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Nov 2016

At a glance

  • Drugs Insulin aspart; Insulin aspart/insulin protamine aspart; Insulin detemir
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms COMMIT-CLEAN-SWITCH
  • Sponsors Novo Nordisk
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 19 Apr 2011 Planned end date changed from 1 Apr 2011 to 1 May 2010 as reported by ClinicalTrials.gov.
    • 19 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top